How effective is whole-pelvic radiation therapy (WPRT) in younger men with unfavorable-risk prostate cancer?
☢️ A new study shows WPRT significantly lowers the risk of death in men under 65. More long-term data is needed.
((A) younger than age 65 years and (B) 65 years or older)…

It's The Lancet Oncology day for Rad Onc GU! Our consensus on SBRT for Oligomets RCC is finally out! Thanks to all the participants! 🔥🔥🔥🌟🌟🌟
Delphi consensus on stereotactic ablative radiotherapy for oligometast... sciencedirect.com/science/articl…

Salvage Reirradiation for Locally Recurrent Prostate Cancer: Results From a Prospective Study With 7.2 Years of Fol… pubmed.ncbi.nlm.nih.gov/38652872/

Absolutely blown away by our visiting professor, Dr. Karen Winkfield , whose passion for improving health equity quickly energized our Department! An afternoon with you was simply not enough! Michael Steinberg MD UCLA Health

Was excellent to have star GU radonc Amar Kishan UCLA as our Sunnybrook Health Sciences Centre Alon Dembo visiting professor sharing his inspiring research on high risk prostate cancer radiation. x.com/DrAndrewLoblaw…

A true honor to be the Alon Dembo Visiting Professor!

Why rush radiotherapy after prostate surgery?
☢️RADICALS-RT trial shows waiting for PSA rise before radiotherapy could be the smarter move – fewer side effects without compromising cancer control. A potential game-changer for post-surgery treatment. #ProstateCancer
Matt Sydes…

Kicking off #EAU24 at the European Urology editorial board meeting. We're collaborating on ways to enhance our content, sharing ideas for new and improved material, and celebrating our remarkable growth over the past year Ruben De Groote Amar Kishan

Now European Urology network meta-analysis
👉 ADT+ARPI+RT is superior relative to ADT+ARPI w/ modest ⬆️ in OS in low volume mHSPC.
👉 In de novo low volume mHSPC no significant difference in OS w/ ADT+RT vs ADT+ARPI after adjustment for docetaxel use. europeanurology.com/article/S0302-…

Is Radiotherapy + radiosensetizer a good option for BCG Unresponsive MIBC with Cis?
EORTC

⭐A phase II trial is coming... led by Vérane Achard
tombal
@dirixpiet Morgan Roupret and Me.

🙏Please find the protocol here :
sciencedirect.com/science/articl…

🩷 fantastic publication by Kent Mouw showing EV and SG combination w/XRT significantly ⬇️tumor size compared to using any agent alone in 🐭.. We are immensely proud at European Urology to publish pioneering bench work that holds the potential to advance patient outcomes Cathy

🚨Our NEW paper out from POP-RT trial Vedang Murthy in IJROBP - The Red Journal !!!🤩

Elective pelvic #radiotherapy in HR-VHR #prostatecancer ⬆️ ⬆️BFFS, DFS, MFS

Does toxicity REALLY increase⁉️
Short: NO
Long: ~10% higher gr2 late urinary (p=NS)
1/

doi.org/10.1016/j.ijro…

Genuinely so fun to chat about all things MR guidance, novel tech, & adaptive w/ Amar Kishan Salma Jabbour Sue Yom & Minsong. As much as hearing my own voice recorded pains me 😅IJROBP - The Red Journal team did a great job sharing our thoughts + making us sound good doing it. Take a listen!☺️

April 1 podcast - cutting edge concepts in MRI, image guidance, and adaptive RT!
Salma Jabbour Amar Kishan Minsong Cao Lauren Henke, MD, MSCI RutgersCancerInstNJ UCLAradonc RadOncUH
Listen at: redjournal.org/pb-assets/Heal…